Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Diabetes

Free Subscription 05.01.2026 1 Am J Hypertens 1 Am J Med 1 Am J Ophthalmol 1 Ann Intern Med 3 Biochem Biophys Res Commun 1 BMC Ophthalmol 1 BMJ 1 Clin Chem 11 Diabet Med 2 Diabetes 5 Diabetes Care 19 Diabetes Obes Metab 5 Diabetologia 1 J Am Coll Cardiol 2 J Clin Endocrinol Metab 3 J Clin Invest 5 J Diabetes Complications 1 J Immunol 1 J Nutr 1 JAMA 4 Lancet 2 Nutr Metab (Lond) 1 Ophthalmol Retina 1 Ophthalmology 2 Pediatr Diabetes 17 PLoS One 3 Proc Natl Acad Sci U S A 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hypertens

1. YADEGAR A, Mohammadi F, Aghayan SN, Heydarzadeh F, et al
   Association of Non-Insulin-Based Markers of Insulin Resistance with Hypertension in Type 2 Diabetes: An Age- and Gender-Matched Cross-Sectional Study.
   Am J Hypertens. 2025 Dec 23:hpaf237. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Med

2. CHUNG J, Park S, Park SJ, Kim HJ, et al
   Fracture Risk by Post-Cessation Weight Change in Men With Newly Diagnosed Type 2 Diabetes.
   Am J Med. 2025 Dec 20:S0002-9343(25)00838-1. doi: 10.1016/j.amjmed.2025.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

3. MURRAY M, Schifano F, Chiappini S, Corkery JM, et al
   Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database.
   Am J Ophthalmol. 2025 Dec 20:S0002-9394(25)00666.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

4. YAN VKC, Blais JE, Gamble JM, Chan EWY, et al
   Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.
   Ann Intern Med. 2025 Dec 30. doi: 10.7326/ANNALS-25-00662.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. THAKUR MR, Tupe RS
   l-Arginine in diabetic cardiomyopathy: Mechanistic insights into RAGE-NF-kappaB-SREBP1 signaling.
   Biochem Biophys Res Commun. 2025;797:153212.
   PubMed         Abstract available
   
   
6. PAN T, Zhu X, Sui Y, Zhang Z, et al
   Tanshinone IIA accelerates diabetic wound healing via suppression of macrophage NLRP3 inflammasome activity.
   Biochem Biophys Res Commun. 2025;797:153171.
   PubMed         Abstract available
   
   
7. CAO H, Xu K, Li X, Liu Q, et al
   Global Sirt5 deletion reshapes gut microbiota and impairs glucose metabolism in high-fat diet-induced obese mice.
   Biochem Biophys Res Commun. 2026;795:153095.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

8. ISMAIL MF, Khalafalla I, Sheck ZO, Isse SAS, et al
   Diabetic retinopathy in Sub-Saharan Africa: prevalence and regional variations from a systematic review and meta-analysis.
   BMC Ophthalmol. 2025 Dec 26. doi: 10.1186/s12886-025-04589.
   PubMed         Abstract available
   
   

   
   BMJ

9. O'DOWD A
   Diabetes prevention: Almost a million people access NHS scheme.
   BMJ. 2025;391:r2686.
   PubMed        
   
   

   
   Clin Chem

10. TORRES C, Kelly J, Gronowski AM
    From Diagnosis to Delivery: A Look at the Continuing Gap in Maternal Testing.
    Clin Chem. 2025;72:27-34.
    PubMed         Abstract available
    
    

    
    Diabet Med

11. MEI X, Li B, Sun L, Tian Y, et al
    Druggable targets and immunological mechanisms for type 1 diabetes treatment: Genetic evidence from multi-omics Mendelian randomization combined with meta-analysis.
    Diabet Med. 2025 Dec 21:e70176. doi: 10.1111/dme.70176.
    PubMed         Abstract available
    
    
12. 
    Correction to "Neonatal diabetes mellitus is a significant feature of COXPD-24 caused by recessive NARS2 variants".
    Diabet Med. 2025 Dec 23:e70199. doi: 10.1111/dme.70199.
    PubMed        
    
    
13. SIMS TJ, Kapoor R, Chinthammit C, Spaepen E, et al
    Relationship between patient activation, experienced stigma, and internalised weight stigma in people with type 2 diabetes.
    Diabet Med. 2025 Dec 25:e70190. doi: 10.1111/dme.70190.
    PubMed         Abstract available
    
    
14. HEIL L, Shipman J, Smalls L, Feo R, et al
    Experiences of young people with type 1 diabetes who have transitioned from paediatric to adult care: A systematic review.
    Diabet Med. 2025 Dec 29:e70188. doi: 10.1111/dme.70188.
    PubMed         Abstract available
    
    
15. ZHU X, Lee ES, Chan FHF, Yin R, et al
    Healing through empowerment and active listening (HEALing): A mixed-methods evaluation of the feasibility and acceptability of a nurse-led self-care support intervention for people with diabetic foot ulcers.
    Diabet Med. 2025 Dec 30:e70187. doi: 10.1111/dme.70187.
    PubMed         Abstract available
    
    
16. LIU W, Xiao W, Zeng Q, Zhou Y, et al
    The exosome-PI3K/Akt-autophagy axis in diabetic vascular complications: Mechanisms and implications.
    Diabet Med. 2025 Dec 30:e70196. doi: 10.1111/dme.70196.
    PubMed         Abstract available
    
    
17. UMAIPALAN V, Tan R, Harris S, Mustafa OG, et al
    Wider determinants of health are crucial confounders in benchmarking treatment standards: Diabetic ketoacidosis as an example.
    Diabet Med. 2025 Dec 31:e70209. doi: 10.1111/dme.70209.
    PubMed        
    
    
18. BARMANRAY RD, Rayman G, Kyi M, Audehm RG, et al
    Leaving better managed than when they arrived: A window of opportunity for people with diabetes admitted to hospital.
    Diabet Med. 2025 Dec 31:e70212. doi: 10.1111/dme.70212.
    PubMed        
    
    
19. MATHEOU A, Zavlis O, White S, McDonnell T, et al
    Progression of albumin/creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) over 24 years in people with type 2 diabetes. Drivers, potential protectors and associated mortality.
    Diabet Med. 2025 Dec 31:e70193. doi: 10.1111/dme.70193.
    PubMed         Abstract available
    
    
20. EHRMANN D, Litterbach E, Deschenes S, Forde R, et al
    From narratives to numbers and back: Assessing the psychosocial aspects of diabetes in the era of high technology with emerging qualitative and quantitative methodologies.
    Diabet Med. 2026 Jan 2:e70206. doi: 10.1111/dme.70206.
    PubMed         Abstract available
    
    
21. YEU RQ, Morrow PL, Braatvedt GD
    Community deaths from diabetic ketoacidosis: A 14-year retrospective study in Auckland, New Zealand.
    Diabet Med. 2025 Dec 21:e70198. doi: 10.1111/dme.70198.
    PubMed         Abstract available
    
    

    
    Diabetes

22. TAN CSH, Kee KX, Zheng H, Wong KWS, et al
    Cluster Analysis of Younger-Onset Type 2 Diabetes in an Asian Cohort Reveals Distinct Subgroups With Differential Pathophysiology and Outcomes.
    Diabetes. 2025 Dec 30:db250871. doi: 10.2337/db25-0871.
    PubMed         Abstract available
    
    
23. LIAO WL, Cheng CW, Chang YW, Lin MC, et al
    Integrating Polygenic Scores and Family History for Type 2 Diabetes Prediction in an East Asian Population: Insights From the Taiwan Biobank.
    Diabetes. 2025 Dec 30:db250357. doi: 10.2337/db25-0357.
    PubMed         Abstract available
    
    

    
    Diabetes Care

24. MATUS AM, Agni A, Amiel SA, Riegel B, et al
    Interoceptive Awareness Moderates the Relationship Between Hypoglycemia Exposure and Symptom Recognition in Adults With Type 1 Diabetes.
    Diabetes Care. 2025 Dec 30:dc252242. doi: 10.2337/dc25-2242.
    PubMed         Abstract available
    
    
25. ZIEGLER J, Holl RW, Biester T, Tauschmann M, et al
    Is Diabetes Technology Associated With Weight Gain in Children and Adolescents With Type 1 Diabetes?
    Diabetes Care. 2025 Dec 24:dc251768. doi: 10.2337/dc25-1768.
    PubMed        
    
    
26. KAHN SE, Tripputi M, Lachin JM, Balasubramanyam A, et al
    Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Diabetes Care. 2025 Dec 23:dc252186. doi: 10.2337/dc25-2186.
    PubMed         Abstract available
    
    
27. DI MARCO M, Bodis KB, Li Z, Mendez Cardenas DM, et al
    Metabolic Factors Modulating the Connection Between Diabetes and Pulmonary Alterations.
    Diabetes Care. 2025 Dec 31:dc252334. doi: 10.2337/dc25-2334.
    PubMed         Abstract available
    
    
28. KARAKUS KE, Akturk HK, Kruger D, Ahmann A, et al
    Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis.
    Diabetes Care. 2025 Dec 22:dc252249. doi: 10.2337/dc25-2249.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

29. HOE B, Heimburger SMN, Gasbjerg LS, Lanng AR, et al
    Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled study.
    Diabetes Obes Metab. 2025 Dec 28. doi: 10.1111/dom.70373.
    PubMed         Abstract available
    
    
30. KONING S, Dekker P, Birnie E, van den Heuvel T, et al
    What is the impact of an advanced hybrid closed-loop system on weight control among people with type 1 diabetes?
    Diabetes Obes Metab. 2025 Dec 28. doi: 10.1111/dom.70410.
    PubMed        
    
    
31. TSAI HR, Hsu JZ, Lee YC, Loh CH, et al
    Risk of diabetic retinopathy and ophthalmic interventions in patients with diabetes mellitus taking different oral anticoagulants.
    Diabetes Obes Metab. 2025 Dec 28. doi: 10.1111/dom.70392.
    PubMed         Abstract available
    
    
32. FOO N, Chodapaneedi S, Gibson B, Koh HJW, et al
    Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review.
    Diabetes Obes Metab. 2025 Dec 28. doi: 10.1111/dom.70401.
    PubMed         Abstract available
    
    
33. VOGT J, Benkhoff M, Schroder NH, Hu H, et al
    Defective high-density lipoprotein lipoprotection in type 2 diabetes during acute myocardial infarction is rescued by apolipoprotein M/sphingosine-1-phosphate loading.
    Diabetes Obes Metab. 2025 Dec 28. doi: 10.1111/dom.70409.
    PubMed         Abstract available
    
    
34. WANG Y, Wang Y, Mu Y, Cheng Y, et al
    Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real-world study.
    Diabetes Obes Metab. 2025 Dec 28. doi: 10.1111/dom.70413.
    PubMed         Abstract available
    
    
35. BHANDARI R, Rhee JW, Chen S, Pillai R, et al
    Association of clonal haematopoiesis and diabetes with outcomes after autologous haematopoietic cell transplantation.
    Diabetes Obes Metab. 2025 Dec 28. doi: 10.1111/dom.70406.
    PubMed        
    
    
36. HOOKER SA, Neugebauer RS, Schmittdiel JA, An J, et al
    Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 2. doi: 10.1111/dom.70415.
    PubMed         Abstract available
    
    
37. THIJS I, Siegelaar SE, Elhenawy YI 1st, Benhalima K, et al
    Challenges in glycaemic control among women with type 1 diabetes and the role of MiniMed 780G system: A narrative review.
    Diabetes Obes Metab. 2026 Jan 2. doi: 10.1111/dom.70377.
    PubMed         Abstract available
    
    
38. YANG C, Denig P, Chepulis L, Paul RG, et al
    Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex.
    Diabetes Obes Metab. 2026 Jan 2. doi: 10.1111/dom.70421.
    PubMed         Abstract available
    
    
39. MORIERI ML, Vedovato M, Bonora BM, Fioretto P, et al
    The importance of treatment sequencing with SGLT2 inhibitors and GLP-1 receptor agonists combination for kidney function preservation in type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 2. doi: 10.1111/dom.70445.
    PubMed         Abstract available
    
    
40. DUTTA D, Mahajan K, Kamrul-Hasan ABM, Mahajan N, et al
    Impact of glucagon-like peptide-1 receptor agonism-based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta-analysis.
    Diabetes Obes Metab. 2025 Dec 22. doi: 10.1111/dom.70391.
    PubMed         Abstract available
    
    
41. GAO JW, Wu YB, Huang ZG, Deng QR, et al
    Comprehensive risk factor control and its biomarker-mediated association with diabetic microvascular complications.
    Diabetes Obes Metab. 2025 Dec 25. doi: 10.1111/dom.70403.
    PubMed         Abstract available
    
    
42. ZHENG C, Cao D, Ma R, Hao X, et al
    Current status of multi-target therapeutics for diabetic macular oedema: Mechanisms and outcomes from clinical trials.
    Diabetes Obes Metab. 2025 Dec 23. doi: 10.1111/dom.70405.
    PubMed         Abstract available
    
    
43. MAHESH S, Anson M, Malik RA, Cuthbertson DJ, et al
    Real-world evaluation of teplizumab in type 1 diabetes: Progression to insulin requirement.
    Diabetes Obes Metab. 2025 Dec 22. doi: 10.1111/dom.70354.
    PubMed        
    
    
44. ZHOU T, Tang H, Zhang B, Zhang D, et al
    Association between glucagon-like peptide-1 receptor agonists and risk of dementia in older adults with type 2 diabetes: A target trial emulation.
    Diabetes Obes Metab. 2025 Dec 22. doi: 10.1111/dom.70384.
    PubMed         Abstract available
    
    
45. SYED AS, Arani G, Macwan S, Koska J, et al
    Obesity and overweight-related differences in cardiometabolic risk factors in type 1 diabetes.
    Diabetes Obes Metab. 2025 Dec 22. doi: 10.1111/dom.70329.
    PubMed         Abstract available
    
    
46. DEDEEPYA SD, Goel V, Desai NN
    Comment on "Associations between gestational diabetes and cardiovascular disease largely operate independently of postpartum causal pathways: A population-based cohort study in England".
    Diabetes Obes Metab. 2025 Dec 22. doi: 10.1111/dom.70402.
    PubMed        
    
    
47. HU H, Wang G, Liang Y, Liu Y, et al
    Spatiotemporal burden, risk factors, and genetic causality of non-alcoholic fatty liver disease and type 2 diabetes mellitus comorbidity in Europe: A multi-database analysis.
    Diabetes Obes Metab. 2025 Dec 22. doi: 10.1111/dom.70398.
    PubMed         Abstract available
    
    

    
    Diabetologia

48. CLAUSSEN C, Papadimos E, Magliano DJ, Hotu C, et al
    Prevalence of type 2 diabetes among global Indigenous adult populations: a systematic review.
    Diabetologia. 2025 Dec 21. doi: 10.1007/s00125-025-06624.
    PubMed         Abstract available
    
    
49. DEWHURST-TRIGG RE, Atkins J, Morgan NG, Eichmann M, et al
    Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetes.
    Diabetologia. 2025 Dec 21. doi: 10.1007/s00125-025-06634.
    PubMed         Abstract available
    
    
50. DENROCHE HC, Ng V, Velghe J, Suen I, et al
    Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice.
    Diabetologia. 2025 Dec 22. doi: 10.1007/s00125-025-06622.
    PubMed         Abstract available
    
    
51. BERTUOL VC JR, Iorra F, Vieceli T, Tonolli NT, et al
    Effects of insulin regimens for type 2 diabetes mellitus: a systematic review and network meta-analysis.
    Diabetologia. 2025 Dec 24. doi: 10.1007/s00125-025-06633.
    PubMed         Abstract available
    
    
52. YUN Y, Liu YD, Yang ZM, Wang YQ, et al
    Duodenal myoelectrical hyperactivity drives diabetic remission in rat models of type 2 diabetes.
    Diabetologia. 2025 Dec 26. doi: 10.1007/s00125-025-06642.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

53. LEE HH, Crawford EB, Cho SMJ, Krawisz AK, et al
    Trends in Prevalence, Treatment, and Control of Cardiometabolic Risk Factors Among Adults With Hypertension in the United States, 1999-2023.
    J Am Coll Cardiol. 2025 Nov 26:S0735-1097(25)09917.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

54. OPPENHEIMER KR, Himelhoch NT, McCullough ME, Bowden TL, et al
    Approach to the Patient - Mitochondrial Diabetes: Contemporary Cases and Precision Medicine Approach.
    J Clin Endocrinol Metab. 2025 Dec 31:dgaf698. doi: 10.1210.
    PubMed         Abstract available
    
    
55. GOSMANOV AR
    Approach to the Patient with Type 2 Diabetes Treated with SGLT-2 Inhibitor: Art of Effective and Safe Prescription.
    J Clin Endocrinol Metab. 2025 Dec 23:dgaf690. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

56. PERSAUD SP, DiPersio JF
    Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and diabetes reversal.
    J Clin Invest. 2026;136:e201105.
    PubMed         Abstract available
    
    
57. REISER J, Hayek SS, Sever S
    The role of suPAR and related proteins in kidney, heart diseases, and diabetes.
    J Clin Invest. 2026;136:e197141.
    PubMed         Abstract available
    
    
58. GILANI A, Stein BD, Hoffmann A, Pereira de Lima R, et al
    Secretory kinase FAM20C triggers adipocyte dysfunction, inciting insulin resistance and inflammation in obesity.
    J Clin Invest. 2025;136:e191075.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

59. LIANG W, Yu H, Deng H, Chen J, et al
    Diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 2 diabetes patients with severe kidney disease: a 7-year retrospective analysis.
    J Diabetes Complications. 2025;40:109253.
    PubMed         Abstract available
    
    
60. BRIGANTI SI, Lanza O, Renzelli V, Campagna G, et al
    Corrigendum to "Impact of technologies on quality of life in relation to glucose control in patients with type 1 diabetes" [JDC, volume 40, issue 1, (2026) 109215].
    J Diabetes Complications. 2025 Dec 20:109254.
    PubMed        
    
    
61. NAKAMURA JE, Fong AJ, Lane AD, Munson ME, et al
    Rethinking diabetic foot ulcer care: Integrating exercise and physical activity.
    J Diabetes Complications. 2025;40:109252.
    PubMed         Abstract available
    
    
62. BAE K, Ryoo NK, Ji YS, Bae JH, et al
    A real-world experience with ranibizumab 0.5 mg initial intensive treatment for diabetic macular edema: 24-week outcomes of the RISING-K study.
    J Diabetes Complications. 2025;40:109251.
    PubMed         Abstract available
    
    
63. HANAI K, Yamashige Y, Mori T, Yamamoto Y, et al
    Effects of high estimated glomerular filtration rate on kidney prognosis in individuals with type 2 diabetes.
    J Diabetes Complications. 2025;40:109255.
    PubMed         Abstract available
    
    

    
    J Immunol

64. CONWAY H, Bernard J, Ramos R, Zahran S, et al
    Altered B cell metabolic pathways characterize type 1 diabetes progression.
    J Immunol. 2025 Dec 27:vkaf330. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Nutr

65. LI L, Wu J, Hao H, Wang Y, et al
    Sialic Acid Supplementation in Perinatal Mice Attenuates Gestational Diabetes Mellitus-induced Liver Injury in Offspring at Early Adulthood.
    J Nutr. 2025 Dec 30:101292. doi: 10.1016/j.tjnut.2025.101292.
    PubMed         Abstract available
    
    

    
    JAMA

66. ANDERER S
    Some Diabetes Drugs May Slow Frailty Progression in Older Adults.
    JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23007.
    PubMed        
    
    

    
    Lancet

67. ARUNDEL C, Mandefield L, Fairhurst C, Gkekas A, et al
    The diabetic foot after SWHSI-2: healing is not one size fits all - Authors' reply.
    Lancet. 2026;406:2925-2926.
    PubMed        
    
    
68. VAS P, Chong P
    The diabetic foot after SWHSI-2: healing is not one size fits all.
    Lancet. 2026;406:2924-2925.
    PubMed        
    
    
69. CHOW EW, Chow E
    Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity.
    Lancet. 2026;406:2866-2868.
    PubMed        
    
    
70. MUSKIET MHA, Nardone M, Rensen PCN, Cherney DZI, et al
    Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
    Lancet. 2026;406:2980-2983.
    PubMed         Abstract available
    
    

    
    Nutr Metab (Lond)

71. XU Y, Duan S, Yin W, Yang Y, et al
    Machine learning-enhanced prediction model for atrial fibrillation development in patients with concurrent type 2 diabetes and obstructive sleep apnea syndrome: a comorbidity perspective.
    Nutr Metab (Lond). 2025;22:158.
    PubMed         Abstract available
    
    
72. WANG S, Xia Y, Han X, Gao Y, et al
    Effects of Sancai Lianmei Granules in type 2 diabetes patients with metabolic dysfunction-associated fatty liver disease: a randomized prospective open-label controlled trial.
    Nutr Metab (Lond). 2025;22:153.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

73. ZHAN J, Sun G, Li H, Deng X, et al
    Timing of Preoperative Anti-VEGF for Vitrectomy in Proliferative Diabetic Retinopathy: A Competing-Risks Analysis of a Large Cohort.
    Ophthalmol Retina. 2025 Dec 29:S2468-6530(25)00600.
    PubMed         Abstract available
    
    

    
    Ophthalmology

74. LIU BBIOMED Z, Raveendran D, Fourlanos S, Chong EW, et al
    Rate and risk of non-arteritic anterior ischaemic optic neuropathy with semaglutide use for diabetes and weight loss: a systematic review and meta-analysis.
    Ophthalmology. 2025 Dec 29:S0161-6420(25)00803.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

75. COCKCROFT EJ, Smith JR, Lloyd J, Johnson L, et al
    Examining the Cognitive, Practical, and Emotional Demands of Managing Physical Activity in Adolescents With Type 1 Diabetes: A Qualitative Study With Adolescents, Parents, and Healthcare Professionals.
    Pediatr Diabetes. 2025;2025:4578096.
    PubMed         Abstract available
    
    
76. ATTIA N, Al Noaim K, Mustafa M, Al Fifi SH, et al
    The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance.
    Pediatr Diabetes. 2025;2025:6859764.
    PubMed         Abstract available
    
    

    
    PLoS One

77. NIU X, Burkemper B, Jiang X
    Trends in self-reported dilated eye examinations among diabetic adults in California from 2011 to 2021.
    PLoS One. 2025;20:e0336246.
    PubMed         Abstract available
    
    
78. XUE J, Cao H, Yang L, Liu J, et al
    Intelligent glucose management in hospitalized patients: Short-term glucose and adverse events prediction.
    PLoS One. 2025;20:e0339360.
    PubMed         Abstract available
    
    
79. NGOLOBE H, Kugonza M, Nkwatsibwe P, Kato A, et al
    Prevalence and factors associated with Intestinal parasitosis among adults with diabetes mellitus attending a tertiary care facility in Northern Uganda: A hospital-based cross-sectional study.
    PLoS One. 2025;20:e0338774.
    PubMed         Abstract available
    
    
80. BRENYAH JK, Twum P, Koranteng ET, Kyei-Dompim J, et al
    Assessment of hypertension and diabetes among lecturers in a Ghanaian university: Setting lifestyle practices as precursors.
    PLoS One. 2025;20:e0338910.
    PubMed         Abstract available
    
    
81. FENG Y, Huang T
    Mechanistic study of plastic monomers in gestational diabetes mellitus: A network toxicology and molecular docking approach.
    PLoS One. 2025;20:e0339863.
    PubMed         Abstract available
    
    
82. DAVAADAMDIN O, Ganbat BE, Baatarsuren U, Tuvdendarjaa K, et al
    Diabetes management cascade in Ulaanbaatar, Mongolia.
    PLoS One. 2025;20:e0337413.
    PubMed         Abstract available
    
    
83. MUKAI K, Ogura K, Nakajima Y, Nakatani T, et al
    The evaluation of the effect of estrogen administration on cutaneous wound healing in Staphylococcus aureus-infected diabetic and nondiabetic mice.
    PLoS One. 2025;20:e0339341.
    PubMed         Abstract available
    
    
84. KAMRAN H, Hussain SJ, Latif S, Soomro IA, et al
    Correction: FedGAN: Federated diabetic retinopathy image generation.
    PLoS One. 2025;20:e0340003.
    PubMed         Abstract available
    
    
85. NAIR NARAYANAN D, Awang S
    Stepping forward: A study protocol for developing and validating a Malaysian diabetic foot self-care practice assessment instrument.
    PLoS One. 2025;20:e0337754.
    PubMed         Abstract available
    
    
86. SALAZAR-GOMEZ A, Flores-Bernal GG, Rojas-Rojas FU, Merino-Perez O, et al
    Trixis angustifolia DC. as a potential plant for the co-management of diabetes mellitus and tuberculosis.
    PLoS One. 2025;20:e0339176.
    PubMed         Abstract available
    
    
87. ANGARITA-MELO PT, Panche-Castellanos K, Rizo-Tello VZ, Forero-Torres AY, et al
    Clinical and social determinants of cardiovascular risk in a population with chronic noncommunicable diseases in Maicao, La Guajira, Colombia: 2024.
    PLoS One. 2025;20:e0340101.
    PubMed         Abstract available
    
    
88. BAISHYA S, Sarangi A, Somvanshi PR, Pasupulati AK, et al
    Gene regulatory networks involved in activation of Notch signaling by AGEs in the pathogenesis of diabetic kidney disease.
    PLoS One. 2026;21:e0335768.
    PubMed         Abstract available
    
    
89. PRUST ML, Lalama CM, Kehlenbrink S, Akinola OA, et al
    Economic evaluation of insulin glargine compared with human insulin for youth with type 1 diabetes in Tanzania and Bangladesh.
    PLoS One. 2026;21:e0333652.
    PubMed         Abstract available
    
    
90. CHEN Y, Luo J, Zheng Y, Jiang X, et al
    A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis.
    PLoS One. 2026;21:e0340096.
    PubMed         Abstract available
    
    
91. SUDA EY, Sartor CD, Passaro AC, Watari R, et al
    Predictive effects of diabetes-related risk factors for falls in community-dwelling people with diabetic peripheral neuropathy based on a logistic regression model.
    PLoS One. 2026;21:e0340262.
    PubMed         Abstract available
    
    
92. TAN NH, Tuan TM, Chuan PM, Hoang ND, et al
    FKG-MM: A multi-modal fuzzy knowledge graph with data integration in healthcare.
    PLoS One. 2026;21:e0339864.
    PubMed         Abstract available
    
    
93. LIAO Y, Spadola C, Roy S
    Mathematical modeling of glucose regulation and sleep resting heart rate to predict risk of metabolic dysregulation in cancer survivors.
    PLoS One. 2026;21:e0339461.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

94. GUAN Y, Yu Y, Fu M, Xu H, et al
    Enhanced insulin signaling via circulating ATG7: A potential therapeutic strategy for diabetes.
    Proc Natl Acad Sci U S A. 2026;123:e2503783123.
    PubMed         Abstract available
    
    
95. FRATUS M, Alam MA
    A closed-loop microneedle-integrated physiological model for predictive glycemic management.
    Proc Natl Acad Sci U S A. 2025;122:e2523517122.
    PubMed         Abstract available
    
    
96. CHAKRABORTY J, Ghosh A, Awuah EB, Stabler SP, et al
    Dietary folic acid prevents peripheral neuropathy in mouse models of neural tube defects and type 2 diabetes.
    Proc Natl Acad Sci U S A. 2026;123:e2528095123.
    PubMed         Abstract available
    
    

    
    Transplantation

97. FILATOV E, Sasaki S, Haque M, Kar S, et al
    CCL22-expressing Stem Cell-derived Islet Grafts Recruit Regulatory T Cells in Mice.
    Transplantation. 2026;110:e116-e128.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.